A randomized trial of saline solution-moistened misoprostol versus dry misoprostol for first-trimester pregnancy failure

被引:32
作者
Gilles, JM [1 ]
Creinin, MD
Barnhart, K
Westhoff, C
Frederick, MM
Zhang, J
机构
[1] Univ Miami, Miami, FL 33152 USA
[2] Univ Pittsburgh, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh, Philadelphia, PA USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Columbia Univ, New York, NY 10027 USA
[6] Clin Trials & Survey Corp, Baltimore, MD USA
[7] Clin Trials & Survey Corp, Bethesda, MD USA
[8] NICHHD, Baltimore, MD USA
[9] NICHHD, Bethesda, MD 20892 USA
关键词
missed abortion; misoprostol; anembryonic pregnancy; fetal death; spontaneous abortion;
D O I
10.1016/j.ajog.2003.08.024
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The purpose of this study was to estimate whether the efficacy of treatment with intravaginal misoprostol for first-trimester pregnancy failure is enhanced by the addition of saline solution. Study design: Eighty women with embryonic/fetal death or anembryonic pregnancy were assigned randomly to receive either 800 mug of misoprostol with saline solution (group I, 41 women) or without (group II, 39 women). Treatment was repeated on day 3 if the gestational sac remained. Curettage was performed if the gestational sac remained on day 8 or as necessary during at least 30 days of follow-up. Data were analyzed with the Student t test and the chi(2) or Fisher exact test. Results: By the first follow-up visit, 73% (group I) and 64% (group II) of women passed the gestational sac (P = .38). By the second follow-up visit, expulsion rates were 83% and 87%, respectively (P = .59). Five subjects in each group underwent curettage. Conclusion: Misoprostol is effective for the treatment of failed first-trimester pregnancy. The expulsion rate is not improved by adding saline solution. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:389 / 394
页数:6
相关论文
共 27 条
[1]   Vaginal misoprostol in the management of first-trimester missed abortions [J].
Ayres-de-Campos, D ;
Teixeira-da-Silva, J ;
Campos, I ;
Patrício, B .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2000, 71 (01) :53-57
[2]   Misoprostol for women's health: A review [J].
Blanchard, K ;
Clark, S ;
Winikoff, B ;
Gaines, G ;
Kabani, G ;
Shannon, C .
OBSTETRICS AND GYNECOLOGY, 2002, 99 (02) :316-332
[3]   CHEMISTRY AND SYNTHETIC DEVELOPMENT OF MISOPROSTOL [J].
COLLINS, PW ;
PAPPO, R ;
DAJANI, EZ .
DIGESTIVE DISEASES AND SCIENCES, 1985, 30 (11) :S114-S117
[4]   Misoprostol for medical evacuation of early pregnancy failure [J].
Creinin, MD ;
Moyer, R ;
Guido, R .
OBSTETRICS AND GYNECOLOGY, 1997, 89 (05) :768-772
[5]   RANDOMIZED CLINICAL-TRIAL OF MEDICAL EVACUATION AND SURGICAL CURETTAGE FOR INCOMPLETE MISCARRIAGE [J].
DEJONGE, ETM ;
MAKIN, JD ;
MANEFELDT, E ;
DEWET, GH ;
PATTINSON, RC .
BRITISH MEDICAL JOURNAL, 1995, 311 (7006) :662-662
[6]   A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure [J].
Demetroulis, C ;
Saridogan, E ;
Kunde, D ;
Naftalin, AA .
HUMAN REPRODUCTION, 2001, 16 (02) :365-369
[7]   MEDICAL-MANAGEMENT OF MISSED ABORTION AND ANEMBRYONIC PREGNANCY [J].
ELREFAEY, H ;
HINSHAW, K ;
HENSHAW, R ;
SMITH, N ;
TEMPLETON, A .
BRITISH MEDICAL JOURNAL, 1992, 305 (6866) :1399-1399
[8]   Drug therapy: Misoprostol and pregnancy. [J].
Goldberg, AB ;
Greenberg, MB ;
Darney, PD .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :38-47
[9]  
GOLDSTEIN SR, 1992, OBSTET GYNECOL, V80, P670
[10]  
HAKIMELAHI E, 1990, OBSTET GYNECOL, V76, P129